Filtreler
Cerebral oxygenation during electroconvulsive therapy [Elektrokonvulsif tedavi sırasında beyin oksijenlenmesi]

Aydin B.G. | Küçükosman G. | Atasoy N.

Article | 2018 | Anadolu Psikiyatri Dergisi19 ( 5 ) , pp.472 - 477

Objective: Electroconvulsive therapy (ECT) is an effective and life-saving treatment modality, while its effects and side effects are still being discussed. In our study, we aimed to demonstrate the effect of O2 administration on the cerebral oxygenation measured by Near Infrared Spectroscopy and the complications after ECT in the apnea period of ECT. Methods: This prospective, observational study was carried out with 40 patients whom ECT had been planned and who were undergoing ECT for the first time. Cerebral oximeter sensors and Bispectral index (BIS) monitoring were applied in all patients as well as routine monitoring. The part . . .icipants were randomly divided into two groups. The patients who received administration of 6 L/min O2 through nasal cannula were included in Group O (n=20), and the patients who were not administered O2 were included in Group C (n=20). Hemodynamic data after induction, during the seizures and at the 10th min after the seizures, EtCO2, regional cerebral tissue oxygen saturation (rSO2), BIS values and complications after ECT were recorded in both groups. Results: No significant difference was determined between the groups with regard to rSO2 alteration values measured during the seizures and demographic characteristics. Desaturation (SpO2<90%) was observed in 12.5% of our patients. Of these five patients, four were in Group C, and one was in Group O. The EtCO2 values after the seizures was found to be significantly higher in Group C. The complication rate after ECT was also high in Group K. Discussion: Cerebral oxygen monitoring does not seem clinically useful in procedures with increased cerebral oxygen consumption, such as that in ECT in which the anesthesia time is short. In addition, it has been concluded that administration of oxygen during apnea may reduce respiratory complications that may occur during and after ECT. © 2018, Cukurova University, Faculty of Medicine. All rights reserved Daha fazlası Daha az

Pseudocholinesterase levels in patients under electroconvulsive therapy

Küçükosman G. | Pişkin Ö. | Hancı V. | Okyay R.D. | Ayoğlu H. | Yurtlu B.S. | Akın M.

Article | 2018 | Saudi Medical Journal39 ( 1 ) , pp.103 - 106

Objectives: In this study, we aimed to retrospectively assess the correlation of pseudocholinesterase (PChE) levels with age, gender, body weight and diagnosed psychiatric diseases in electroconvulsive therapy (ECT) cases. Methods: This retrospective study was conducted at Bülent Ecevit University Hospital, Zonguldak, Turkey, between 2007 and 2011. In the study, 193 ECT case files were retrospectively scanned to evaluate PChE values before ECT and other file information. Results: There was no difference between gender in terms of PChE levels. Correlation analysis determined a weakly positive correlation between age (p=0.013; correla . . .tion coefficient [cc]: 0.178) and body weight ( Daha fazlası Daha az

The effects of propofol and propofol-alfentanil used in electroconvulsive therapy on duration of convulsion, hemodynamic responses and recovery characteristics [Elektrokonvülsif tedavide propofol ile propofol+alfentanil'in konvülsiyon süresi, hemodina?ik yanitlar ve derlenme üzerine etk?ileri]

Demirel C.B. | Kati I. | Koçoglu H. | Hüseyinoglu Ü.A. | Silay E.

Article | 2002 | Anestezi Dergisi10 ( 3 ) , pp.203 - 206

The aim of this study was to investigate the effects of propofol and propofol-alfentanil combination used in Electroconvulsive therapy (ECT) on duration of convulsion, hemodynamic responses cardiovascular system and recovery characteristics. Arterial blood pressure, heart rate, peripheral oxygen saturation, and electrocardiogram were monitored during the ECT procedure. Patients were randomized into two groups (Group I: propofol, n:16, Group II: propofol+alfentanil, n:16). After premedication with atropine, the G I received propofol 0.75 mg kg-1 and the G II received propofol 0.50 mg kg-1 and alfentanil 20, µg kg-1 Additional propofo . . .l was given as needed in 0.1 mg kg-1 increments until loss of consciousness. Suxamethonium 1.0 mg kg-1 IV was given for muscular paralysis. The electrical stimulus was administered immediately after resolution of fasciculations. Mean motor convulsion duration were longer with propofol-alfentanil than with propofol. Hemodynamic responses and recovery characteristics were similar for the two groups. We concluded that the combination of propofol with alfentanil is a better combination for ECT Daha fazlası Daha az

6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms